Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 63
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do post-industrial landscapes affect American Woodcock breeding success?

    I study American Woodcock breeding success in post-industrial habitat to see if human altered habitat can...

    E pluribus unum: how honey bee bacteria coordinate behaviors

    The honey bee is a charismatic species that plays a critical role in the pollination of agriculturally important...

    Are biofilms responsible for heavy metals on plastic debris?

    I want to know how ocean bacteria and algae that live on plastic debris influence the toxins plastic picks...

    Backer Badge Funded